Home Medinol

Medinol

In operation
-
Drug-Eluting Stent Developer
Basic
Enterprise Profile

Basic Information

Medinol, founded by Dr. Judith Richter and Dr. Jacob (Kobi) Richter in 1992, is dedicated to the science of cardiovascular intervention. Medinol develops, manufactures, and markets EluNIR™, the first flexible drug-eluting stent. Made from thin cobalt-chromium alloy, EluNIR is renowned for its unique flexibility, consistency, and scaffolding properties, offering a new level of uniform drug elution and surface quality. It has demonstrated excellent clinical outcomes and promising safety in two clinical studies. EluNIR has received FDA approval and CE marking, showcasing outstanding clinical results and encouraging safety in two clinical trials. It incorporates Flexx² catheter technology with a metallic spring tip, enabling unprecedented ease of use even in challenging anatomies.
Medinol, Ltd.
TelAviv,TelAvivDistrict,Israel
101~500 people
December 01, 1992
contact@medinol.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design
Concept
Cardiology Department Cardiovascular Disease Adjuvant Therapy Products
Application Scenarios
High-Value Medical Consumables